GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 89 filers reported holding GRITSTONE ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,323 | -11.8% | 4,839 | 0.0% | 0.00% | – |
| Q2 2023 | $9,436 | -93.0% | 4,839 | -53.5% | 0.00% | -100.0% |
| Q4 2021 | $133,924 | +19.1% | 10,414 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $112,471 | +15.7% | 10,414 | -2.2% | 0.00% | +100.0% |
| Q2 2021 | $97,225 | +34.3% | 10,649 | +38.7% | 0.00% | 0.0% |
| Q1 2021 | $72,394 | +5.8% | 7,677 | -25.5% | 0.00% | 0.0% |
| Q2 2020 | $68,432 | +27.3% | 10,306 | +11.6% | 0.00% | 0.0% |
| Q1 2020 | $53,736 | -36.0% | 9,233 | -5.1% | 0.00% | 0.0% |
| Q3 2019 | $84,019 | +255.4% | 9,730 | +358.5% | 0.00% | – |
| Q2 2019 | $23,639 | – | 2,122 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $41,970,000 | 8.18% |
| Copernicus Capital Management, LLC | 37,000 | $349,000 | 5.64% |
| EcoR1 Capital, LLC | 3,421,287 | $32,263,000 | 1.43% |
| Palo Alto Investors LP | 2,298,382 | $21,674,000 | 1.24% |
| AlpInvest Partners B.V. | 226,866 | $2,139,000 | 1.06% |
| Stenahm Asset Managment Ltd | 150,000 | $1,415,000 | 1.00% |
| FRAZIER MANAGEMENT LLC | 1,030,878 | $9,721,000 | 0.78% |
| BVF INC/IL | 1,861,239 | $17,551,000 | 0.66% |
| Avidity Partners Management LP | 2,122,064 | $20,011,000 | 0.55% |
| Redmile Group, LLC | 2,448,158 | $23,086,000 | 0.32% |